Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease
Yinghong Li, Ying Han, Qi Shu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117814-117814
Open Access | Times Cited: 2
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies
Haohui Fan, Kun Wang, Xiaofang Zhao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets
Priyanka Soni, Navneet Ammal Kaidery, Sudarshana M. Sharma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease
Wolfgang J. Streit, Leah Phan, Ingo Bechmann
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100005-100005
Open Access | Times Cited: 5
Copper and cuproptosis: new therapeutic approaches for Alzheimer’s disease
Xiao Li, Xinwang Chen, Xiyan Gao
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 11
Exosomes inhibit ferroptosis to alleviate intervertebral disc degeneration via the p62-KEAP1-NRF2 pathway
Chao Chen, Xuenan Wang, Yueqin Zhao, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Inhibition of lysyl oxidase by pharmacological intervention and genetic manipulation alleviates epilepsy-associated cognitive disorder
Kang-Ni Chen, Qilin Peng, Danfeng Cao, et al.
Brain Research Bulletin (2024) Vol. 210, pp. 110928-110928
Open Access | Times Cited: 1
Construction and validation of a bioinformatics‑based screen for cuproptosis‑related genes and risk model for Alzheimer's disease
Rui Hu, Zhen Xiao, Mingyu Qiao, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 1
A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment
Arif Jamal Siddiqui, Riadh Badraoui, Mohammed Merae Alshahrani, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0306579-e0306579
Open Access | Times Cited: 1
BCL2 interacting protein 3 as a potential biomarker for Alzheimer’s disease: an observational study
Pengtao Zheng, Xudong Huang, Xinping Pang, et al.
NeuroMarkers. (2024) Vol. 1, Iss. 1, pp. 100005-100005
Open Access | Times Cited: 1
Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein
Chang Liu, Xuying Ding, Mei-Jun Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116661-116661
Open Access
Oral administration of butylated hydroxytoluene induces neuroprotection in a streptozotocin-induced rat Alzheimer’s disease model via inhibition of neuronal ferroptosis
Parisa Faraji, Elham Parandavar, Hartmut Kühn, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
The study on cuproptosis in Alzheimer’s disease based on the cuproptosis key gene FDX1
Guilin Chen, Erwei Xi, Xiaozhen Gu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Page 1

Scroll to top